Those holding Shanghai MicroPort EP MedTech Co., Ltd. (SHSE:688351) shares would be relieved that the share price has rebounded 25% in the last thirty days, but it needs to keep going to repair the recent damage it has caused to investor portfolios. Unfortunately, despite the strong performance over the last month, the full year gain of 9.2% isn’t as attractive.
Since its price has surged higher, Shanghai MicroPort EP MedTech may be sending strong sell signals at present with a price-to-sales (or “P/S”) ratio of 36.6x, when you consider almost half of the companies in the Medical Equipment industry in China have P/S ratios under 5.8x and even P/S lower than 2x aren’t out of the ordinary. Although, it’s not wise to just take the P/S at face value as there may be an explanation why it’s so lofty.
Check out our latest analysis for Shanghai MicroPort EP MedTech
